VIANVAC® (Vianvac)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceVaccine for the prevention of typhoid feverVaccine for the prevention of typhoid fever
Dosage form: & nbsp

hypodermic solution

Composition:Composition per one ampoule:
Active substance: Vi-antigen - 0.025 mg,
Excipients: phenol (preservative) - not more than 0.75 mg, sodium chloride - 4.2 mg, sodium phosphate disubstituted - 0.052 mg, sodium phosphate monosubstituted - 0.017 mg, water for injection - 0.5 ml.
Description:

Colorless transparent or slightly opalescent liquid.

Pharmacotherapeutic group:MIBP vaccine
ATX: & nbsp

J.07   Vaccines

Pharmacodynamics:

IMMUNOLOGICAL PROPERTIES

The introduction of the vaccine leads to a rapid intensive appearance in the blood of vaccinated specific B-antibodies, providing in 1-2 weeks immunity to infection, lasting at least three years.

Indications:

Prevention of typhoid fever in adults and children aged three years.

Priority vaccination is subject to:

- population living in areas with a high incidence of typhoid fever;

- population living in the territories in chronic aquatic epidemics of typhoid fever;

- persons engaged in the sphere of public amenities (workers serving sewer networks, structures and equipment, as well as enterprises for sanitary cleaning of populated areas - collection, transportation and disposal of domestic waste);

- persons working with live cultures of typhus;

- persons departing for regions and countries that are hyperendemic by typhoid fever, as well as by contact points in epideptic sites.

According to epidemic indications, vaccinations are carried out with the threat of an epidemic or an outbreak (natural disasters, major accidents at the water and sewerage network), contact in the outbreaks for epidemic indications, and during the epidemic.

Contraindications:

  • Acute infectious and non-infectious diseases, exacerbation of chronic diseases. Vaccinations are carried out 1 month after recovery (remission).
  • Strong and unusual reactions to the previous administration of the vaccine, VIANVAC®.
  • Pregnancy.

In order to identify contraindications, the doctor (paramedic) on the day of vaccination conducts a survey and examination of the vaccine with mandatory thermometry. If necessary, conduct appropriate laboratory examination.

Dosing and Administration:

Inoculations are performed once.

The vaccine is injected subcutaneously into the outer surface of the upper third of the shoulder. The vaccine dose for all ages is 0.5 ml.

Revaccinations are carried out according to indications every 3 years.

The preparation is not suitable for use in ampoules with broken integrity or marking, as well as when changing its physical properties, expired shelf life, improper storage.

The drug from the opened ampoule should be used immediately. Opening of ampoules and the procedure for administering the drug are carried out with strict adherence to aseptic and antiseptic rules.

The vaccination is recorded in the prescribed registration forms with the name of the preparation, the date of vaccination, the dose, the number of the series and the response to the vaccine, if any.

Side effects:

Reactions to administering the vaccine are quite rare and are regarded as weak. They can appear during the first day after immunization in the form of redness, tenderness at the site of grafting, as well as a slight increase in temperature (less than 37.6 ° C in 3-5% of cases for 24-48 hours), headache.

Interaction:

Vaccine "VIANVAC®",inactivated vaccines of the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemic indications can be administered simultaneously by different syringes in different parts of the body or at intervals of 1 month.

Form release / dosage:

Solution for subcutaneous administration 0.5 ml / dose.

Packaging:In ampoules of 0.5 ml (1 inoculation dose), 2.5 ml (five vaccination doses), 5 or 10 ampoules per pack or in a bundle with a blister pack. In bottles of 10 ml (20 vaccine doses).
Storage conditions:

The vaccine is stored and transported in accordance with SP 3.3.2.1248-03 at a temperature of 2 to 25 ° C. Transportation is allowed at temperatures up to 35 ° C for no more than 14 days.

Vaccine VIANVAC® should be stored in places not available for children.

Shelf life:Shelf life is three years. The drug with expired shelf life is not subject to application.
Terms of leave from pharmacies:For hospitals
Registration number:P N000183 / 01
Date of registration:31.03.2011
Expiration Date:Unlimited
The owner of the registration certificate:GRITVAK, LLC GRITVAK, LLC Russia
Manufacturer: & nbsp
Information update date: & nbsp09.01.2017
Illustrated instructions
    Instructions
    Up